GE HealthCare Technologies Inc. (GEHC)
Cash ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | ||
|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 2,874,000 | 3,550,000 | 1,997,000 | 2,551,000 | 2,494,000 | 2,408,000 |
| Short-term investments | US$ in thousands | 15,000 | 442,000 | — | — | — | — |
| Total current liabilities | US$ in thousands | 9,553,000 | 8,670,000 | 8,318,000 | 8,859,000 | 8,981,000 | 7,565,000 |
| Cash ratio | 0.30 | 0.46 | 0.24 | 0.29 | 0.28 | 0.32 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($2,874,000K
+ $15,000K)
÷ $9,553,000K
= 0.30
The cash ratio of GE HealthCare Technologies Inc. has shown some fluctuation over the past year. As of December 31, 2023, the cash ratio was 0.28, indicating that the company had $0.28 in cash and cash equivalents for every $1 of current liabilities. The ratio increased slightly to 0.29 by March 31, 2024, and then decreased to 0.24 by June 30, 2024.
However, there was a significant improvement in the cash ratio by September 30, 2024, where it was reported at 0.46. This indicates that the company had a strong liquidity position at that point in time. By December 31, 2024, the cash ratio declined slightly to 0.30.
Overall, the trend in the cash ratio of GE HealthCare Technologies Inc. indicates some variability in the company's ability to cover its short-term obligations with its cash holdings. The higher ratio in the latest period suggests an improved liquidity position, but it would be important to monitor future changes in the ratio to assess the company's ongoing liquidity management.
Peer comparison
Dec 31, 2024